The Veterinary Medicines Regulations 2008

1. Introductory Text

2. PART 1

   1. 1. Title and commencement

   2. 2. Definition of “veterinary medicinal product”, interpretation and scope

   3. 3. Products to which these Regulations do not apply

3. PART 2

   1. 4. Placing a veterinary medicinal product on the market

   2. 5. Manufacture of veterinary medicinal products

   3. 6. The finished product

   4. 7. Classification, supply and possession of the product

   5. 8. Administration of the product

   6. 9. Importation of authorised veterinary medicinal products

   7. 10. Advertising the product

   8. 11. Advertising of prescription products and products containing psychotropic drugs or narcotics

   9. 12. Defence of publication in the course of business

   10. 13. Wholesale dealing

   11. 14. Feedingstuffs

   12. 15. Exemptions

   13. 16. Fees

4. PART 3

   1. 17. Food-producing animals: proof of purchase of veterinary medicinal products

   2. 18. Food-producing animals: records of administration by a veterinary surgeon

   3. 19. Food-producing animals: records of acquisition and administration

   4. 20. Food-producing animals: retention of records

   5. 21. Records by a holder of a manufacturing authorisation

   6. 22. Records by a holder of a wholesale dealer’s authorisation

   7. 23. Records of the receipt or supply of prescription products

   8. 24. Records of products administered to a food-producing animal under the cascade

5. PART 4

   1. 25. Importation of an unauthorised veterinary medicinal product

   2. 26. Possession of an unauthorised veterinary medicinal product

   3. 27. Supply of an unauthorised veterinary medicinal product

6. PART 5

   1. 28. The Veterinary Products Committee

   2. 29. Veterinary Products Committee appeals procedure

   3. 30. Appeals to an appointed person

   4. 31. Exports

   5. 32. Time limits

   6. 33. Appointment of inspectors

   7. 34. Powers of entry

   8. 35. Powers of an inspector

   9. 36. Inspection of pharmacies

   10. 37. Obstruction

   11. 38. Improvement notices

   12. 39. Appeals against improvement notices

   13. 40. Powers of a court on appeal

   14. 41. Seizure notices

   15. 42. Publication

   16. 43. Penalties

   17. 44. Northern Ireland

   18. 45. Revocations and consequential amendment

7. Signature

8. 1. SCHEDULE 1

      Marketing authorisations

      1. PART 1

         1. 1. Application for a marketing authorisation

         2. 2. Information with the application

         3. 3. Summary of product characteristics

         4. 4. Supply of a copy of the summary of product characteristics

         5. 5. Time limits for applications for products for use in food-producing animals

      2. PART 2

         1. 6. Scope

         2. 7. Bibliographic application

         3. 8. Application for a product using a new combination of active substances

         4. 9. Application using existing data

         5. 10. Application for a pharmacologically equivalent medicinal product

         6. 11. Time limits for marketing authorisations granted under the procedure for a pharmacologically equivalent product

         7. 12. Extension of time limits

         8. 13. Parallel imports

         9. 14. Specific batch control scheme

         10. 15. Similar immunological products

         11. 16. Marketing in exceptional circumstances

      3. PART 3

         1. 17. Time limits

         2. 18. Place of establishment of applicant

         3. 19. Procedure

         4. 20. Products authorised in another member State

         5. 21. Assessment reports

         6. 22. Grant of a marketing authorisation

         7. 23. Marketing authorisations for food-producing species

         8. 24. Refusal of a marketing authorisation

         9. 25. Publication following the grant of a marketing authorisation

         10. 26. Provisional marketing authorisation

         11. 27. Provisions of samples and expertise

         12. 28. Supply of information

         13. 29. Duties on the holder of a marketing authorisation relating to an immunological product

         14. 30. Control tests

         15. 31. Placing on the market

         16. 32. Duration and validity of a marketing authorisation

      4. PART 4

         1. 33. Variation of a marketing authorisation for a mutually recognised veterinary medicinal product

         2. 34. Variation of a marketing authorisation not authorised in another member State

         3. 35. Administrative variations

         4. 36. Changes after a marketing authorisation has been issued

         5. 37. Compulsory variation

      5. PART 5 etc.

         1. 38. Suspension of a marketing authorisation: grounds

         2. 39. Suspension of a marketing authorisation: procedure

         3. 40. Revocation

         4. 41. Prohibiting the supply of veterinary medicinal products

      6. PART 6

         1. 42. Application for a marketing authorisation where one already exists in another member State

         2. 43. Application in another member State

         3. 44. Application for a marketing authorisation in multiple member States where a marketing authorisation does not exist in any member State

      7. PART 7

         1. 45. Approval by the Secretary of State

         2. 46. Reference to being authorised

         3. 47. Language

         4. 48. Labelling with all the information on the immediate packaging

         5. 49. Products with immediate and outer packaging

         6. 50. Package leaflets

         7. 51. Ampoules

         8. 52. Small containers other than ampoules

         9. 53. Homeopathic remedies

         10. 54. Variations

      8. PART 8

         1. 55. Qualified persons responsible for pharmacovigilance

         2. 56. Duties relating to the qualified person

         3. 57. Adverse reactions to a veterinary medicinal product administered in the United Kingdom

         4. 58. Adverse reactions to a veterinary medicinal product administered in a third country

         5. 59. Periodic safety update reports

         6. 60. Release of information by the marketing authorisation holder

         7. 61. Action taken on account of pharmacovigilance

      9. PART 9

         1. 62. Meaning of “homeopathic remedy”

         2. 63. Placing a homeopathic remedy on the market in accordance with a registration

         3. 64. Application for registration

         4. 65. Procedure for registration

         5. 66. Products on the market before 1994

         6. 67. Classification

   2. SCHEDULE 2

      The manufacture of veterinary medicinal products

      1. PART 1

         1. 1. Application

         2. 2. Time limits

         3. 3. Granting the authorisation

         4. 4. The authorisation

         5. 5. Suspension, variation or revocation of the authorisation

         6. 6. Inspection of premises

         7. 7. Report following inspection

         8. 8. Duties on the holder of a manufacturing authorisation

         9. 9. Qualified persons for manufacture

         10. 10. Refusal or revocation of appointment

         11. 11. Duties on a qualified person

         12. 12. Register

         13. 13. Test sites

      2. PART 2

         1. 14. Authorisation to manufacture autogenous vaccines

         2. 15. Types of authorisation

         3. 16. Labelling

         4. 17. Records

         5. 18. Adverse reactions

         6. 19. Inspection of premises

      3. PART 3

         1. 20. Authorisation of blood banks

         2. 21. Supply and administration of blood from a blood bank

         3. 22. Labelling

         4. 23. Records

         5. 24. Inspection of blood banks

      4. PART 4

         1. 25. Authorisation to manufacture products for administration under the cascade

         2. 26. Labelling

         3. 27. Records

         4. 28. Adverse reactions

         5. 29. Inspection of premises

      5. PART 5

         1. 30. Authorisation of stem cell centres

         2. 31. Supply and administration of stem cells

         3. 32. Labelling

         4. 33. Records

         5. 34. Inspection of equine stem cell centres

   3. SCHEDULE 3

      Classification and supply, wholesale dealers and sheep dip

      1. PART 1

         1. 1. Classification of veterinary medicinal products

         2. 2. Wholesale supply of veterinary medicinal products

         3. 3. Retail supply of veterinary medicinal products

         4. 4. Prescriptions by a veterinary surgeon

         5. 5. Prescriptions

         6. 6. Written prescriptions

         7. 7. Duties when a product is prescribed or supplied

         8. 8. Supply by a veterinary surgeon from registered practice premises

         9. 9. Supply by a veterinary surgeon

         10. 10. Supply by a pharmacist

         11. 11. Supply of a veterinary medicinal product for incorporation into feedingstuffs

         12. 12. Labelling at the time of retail supply

         13. 13. Supply of veterinary medicinal products for use under the cascade

         14. 14. Supply by a suitably qualified person

         15. 15. Annual audit

      2. PART 2

         1. 16. Application

         2. 17. Time limits

         3. 18. Granting the authorisation

         4. 19. The authorisation

         5. 20. Suspension, variation or revocation of the authorisation

         6. 21. Duties on the holder of a wholesale dealer’s authorisation

      3. PART 3

         1. 22. Supply of sheep dip

         2. 23. Use of sheep dip

   4. SCHEDULE 4

      Administration of a veterinary medicinal product outside the terms of a marketing authorisation

      1. 1. Administration under the cascade

      2. 2. Withdrawal periods

      3. 3. Administration to food-producing horses

      4. 4. Immunological products for serious epizootic disease

      5. 5. Immunological products for an imported or exported animal

      6. 6. Administration by veterinary surgeons from other member States

      7. 7. Treatment in exceptional circumstances

      8. 8. Administration of a homeopathic remedy

      9. 9. Administration under an animal test certificate

   5. SCHEDULE 5

      Medicated feedingstuffs and specified feed additives

      1. 1. Scope and interpretation

      2. 2. Enforcement of Regulation (EC) No. 178/2002

      3. 3. Enforcement of Regulation (EC) No. 1831/2003

      4. 4. Enforcement of Regulation (EC) No. 882/2004

      5. 5. Enforcement of Regulation (EC) No. 183/2005

      6. 6. Approval of manufacturers and distributors of feedingstuffs containing veterinary medicinal products

      7. 7. Incorporation of a veterinary medicinal product into a premixture

      8. 8. Incorporation of a veterinary medicinal product into feedingstuffs

      9. 9. Additional record keeping requirements relating to veterinary medicinal products

      10. 10. Labelling a premixture containing a veterinary medicinal product

      11. 11. Labelling of feedingstuffs containing a specified feed additive

      12. 12. Labelling of feedingstuffs containing a veterinary medicinal product

      13. 13. Supply of specified feed additives

      14. 14. Supply of premixture

      15. 15. Supply of feedingstuffs containing a veterinary medicinal product

      16. 16. Prescriptions for feedingstuffs containing a veterinary medicinal product

      17. 17. Writing the prescription

      18. 18. Possession

      19. 19. Sampling and analysis

      20. 20. Storage

      21. 21. Packages and other containers

      22. 22. Transport

      23. 23. Possession, placing on the market and use of feedingstuffs

      24. 24. Imports from third countries

      25. 25. Trade between member States

      26. 26. Import for incorporation into premixture or feedingstuffs for export

      27. 27. Animals on domestic premises

   6. SCHEDULE 6

      Exemptions for small pet animals

      1. 1. Animals to which this Schedule applies

      2. 2. Placing on the market, importing and administering the product

      3. 3. Manufacture

      4. 4. Approval of the active substance

      5. 5. The product

      6. 6. Labelling

      7. 7. Administration

      8. 8. Pack size

      9. 9. Adverse reactions

   7. SCHEDULE 7

      Fees

      1. PART 1

         1. 1. Interpretation

         2. 2. Payment of fees

         3. 3. Time of payment

         4. 4. Multiple inspections

         5. 5. Expenses for inspections

         6. 6. Translation

      2. PART 2

         1. 7. Fees for specified pharmaceutical applications

         2. 8. Decentralised pharmaceutical application where the United Kingdom is the reference member State

         3. 9. Application for a marketing authorisation for an immunological product

         4. 10. Decentralised immunological application where the United Kingdom is the reference member State

         5. 11. Application for a marketing authorisation using identical data

         6. 12. Application for a provisional marketing authorisation (pharmaceutical)

         7. 13. Fees for an application for a provisional marketing authorisation (immunological)

         8. 14. Fee for the conversion from a provisional to a full marketing authorisation

         9. 15. Application for a marketing authorisation relating to a parallel import

         10. 16. Application for a variation

         11. 17. Application for a variation to a marketing authorisation that has been issued in other member States

         12. 18. Application for an extension to a marketing authorisation

         13. 19. Decentralised application for an extension where the United Kingdom is the reference member State

         14. 20. Provision of information relating to the recognition of a United Kingdom marketing authorisation

         15. 21. Application for the renewal of a national marketing authorisation

         16. 22. Application for the renewal of a marketing authorisation granted in more than one member State

         17. 23. Registration of a homeopathic remedy

         18. 24. Annual fees for marketing authorisations

         19. 25. Auditor’s certificate

         20. 26. Late payment of annual fees

      3. PART 3

         1. 27. Application for a manufacturing authorisation

         2. 28. Application for a variation of a manufacturing authorisation

         3. 29. Application for an authorisation to manufacture an autogenous vaccine or a product for administration under the cascade

         4. 30. Annual fees

         5. 31. Site inspections – type of site

         6. 32. Inspection of a site where immunological veterinary medicinal products are manufactured

         7. 33. Inspection of a site where sterile veterinary medicinal products are manufactured

         8. 34. Inspection of a site where no immunological or sterile veterinary medicinal products are manufactured

         9. 35. Inspection of a site where veterinary medicinal products are assembled

         10. 36. Test sites

         11. 37. Animal blood bank or equine stem cell centre authorisations

      4. PART 4

         1. 38. Application for a wholesale dealer’s authorisation

         2. 39. Variation of a wholesale dealer’s authorisation

         3. 40. Annual fee for a wholesale dealer’s authorisation

         4. 41. Inspection of a wholesale dealer’s premises

      5. PART 5

         1. 42. Fees relating to feedingstuffs

         2. 43. Fees relating to premises for supply by suitably qualified persons

         3. 44. Reduced fees

      6. PART 6

         1. 45. Testing samples

         2. 46. Animal test certificates

         3. 47. Treatment under the cascade

         4. 48. Treatment under the Animals (Scientific Procedures) Act 1986

         5. 49. Treatment in exceptional circumstances

         6. 50. Specific batch control

         7. 51. Submission of control tests of an immunological product

         8. 52. Export certificates

         9. 53. Appeals to the Veterinary Products Committee: marketing authorisations and ATCs

         10. 54. Appeals to the Veterinary Products Committee: variations

         11. 55. Appeal to the Veterinary Products Committee: suspensions

         12. 56. Appeal to the Veterinary Products Committee: active substance under Schedule 6

         13. 57. Fee relating to an appointed person

         14. 58. Fee for the inspection of a veterinary surgeon’s practice premises

         15. 58A. Fee for the registration of veterinary practice premises

         16. 59. Refund of fees relating to the Veterinary Products Committee or appointed persons

         17. 60. Fees relating to an improvement notice

         18. 61. Non-payment of fees

         19. 62. Waiver or reduction of fees

         20. 63. Reduction of fees when an application is withdrawn

9. Explanatory Note